Beijing, China

Jiantao Xu

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Beijing Baishihekang Pharmaceutical Technology (Bsjpharma) Co., Ltd, Chinese Academy of Medical Sciences. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jiantao Xu. Retrieved from https://idiyas.com/inventor/jiantao-xu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jiantao Xu: Innovator in Medical Science

Introduction

Jiantao Xu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medical science, particularly in the area of fibroplasia treatment. With a total of two patents to his name, Xu's work is recognized for its innovative approach to medical challenges.

Latest Patents

Jiantao Xu's latest patents focus on the use of microRNA in the prevention and treatment of fibroplasia medical signs and syndromes. His patents detail the provision of microRNA derived from aroot and its applications in addressing fibroplasia. These inventions highlight the potential of microRNA as a therapeutic agent in medical science.

Career Highlights

Throughout his career, Jiantao Xu has worked with esteemed organizations such as the Chinese Academy of Medical Sciences and Beijing Baishihekang Pharmaceutical Technology Co., Ltd. His experience in these institutions has allowed him to develop and refine his innovative ideas in medical research.

Collaborations

Jiantao Xu has collaborated with notable colleagues, including Chengyu Jiang and Jianchao Du. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Jiantao Xu's contributions to medical science through his patents and collaborations demonstrate his commitment to innovation in healthcare. His work continues to pave the way for new treatments and advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…